{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:57:17Z","timestamp":1785225437509,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.bmcl.2013.02.029","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T02:46:20Z","timestamp":1360896380000},"page":"2391-2394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Synthesis and evaluation of 3-(benzylthio)-5-(1H-indol-3-yl)-1,2,4-triazol-4-amines as Bcl-2 inhibitory anticancer agents"],"prefix":"10.1016","volume":"23","author":[{"given":"Rania","family":"Hamdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Ziedan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El-Sadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsaid","family":"Lashin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Brancale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwyn T.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Westwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2013.02.029_b0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.molcel.2010.01.025","volume":"37","author":"Chipuk","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bmcl.2013.02.029_b0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2013.02.029_b0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1517\/13543776.2012.644274","volume":"22","author":"Bajwa","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bmcl.2013.02.029_b0020","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1078-0432.CCR-08-0144","volume":"15","author":"Kang","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bmcl.2013.02.029_b0025","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2013.02.029_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399408000641","volume":"10","author":"White","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.bmcl.2013.02.029_b0035","doi-asserted-by":"crossref","first-page":"19512","DOI":"10.1073\/pnas.0709443104","volume":"104","author":"Nguyen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bmcl.2013.02.029_b0040","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2174\/138955708784567430","volume":"8","author":"Ziedan","year":"2008","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bmcl.2013.02.029_b0045","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1016\/j.ejmech.2010.07.012","volume":"45","author":"Ziedan","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bmcl.2013.02.029_b0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejmech.2012.08.009","volume":"56","author":"Tohid","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bmcl.2013.02.029_b0055","first-page":"1565","volume":"48B","author":"Begum","year":"2009","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.bmcl.2013.02.029_b0075","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1021\/jm901757t","volume":"53","author":"Brahemi","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmcl.2013.02.029_b0080","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1038\/sj.onc.1202650","volume":"18","author":"Li","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bmcl.2013.02.029_b0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s002800050767","volume":"41","author":"Elliott","year":"1998","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bmcl.2013.02.029_b0090","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/mt.2011.175","volume":"19","author":"Watkins","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bmcl.2013.02.029_b0095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ccr.2008.09.002","volume":"14","author":"Kolluri","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bmcl.2013.02.029_b0100","first-page":"971","volume":"9","author":"Rao","year":"2011","journal-title":"J. Trans. Med."},{"key":"10.1016\/j.bmcl.2013.02.029_b0105","unstructured":"Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank (PDB), http:\/\/www.rcsb.org\/pdb."},{"key":"10.1016\/j.bmcl.2013.02.029_b0110","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.bmcl.2012.04.103","volume":"22","author":"Perez","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2013.02.029_b0115","unstructured":"Molecular Operating Environment (MOE). Chemical Computing Group, Inc. Montreal, Quebec, Canada, http:\/\/www.chemcomp.com."},{"key":"10.1016\/j.bmcl.2013.02.029_b0120","unstructured":"BioSolveIT GmbH. http:\/\/www.biosolveit.de\/LeadIT."},{"key":"10.1016\/j.bmcl.2013.02.029_b0125","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1021\/jm060460o","volume":"49","author":"Wang","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmcl.2013.02.029_b0130","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1158\/1535-7163.MCT-08-0333","volume":"7","author":"Meng","year":"2008","journal-title":"Mol. Cancer Ther."}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X13002059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X13002059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T06:42:55Z","timestamp":1760769775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X13002059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0960894X13002059"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2013.02.029","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of 3-(benzylthio)-5-(1H-indol-3-yl)-1,2,4-triazol-4-amines as Bcl-2 inhibitory anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2013.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}